Current dividend yield | 5.72 % |
Dividendenrendite 5 Jahre | 9.86 % |
Dividend Yield 10Y | 8.76 % |
Payout 3Y | 7.24 % |
The Hansoh Pharmaceutical Group Company stock dividend is paid 2 times a year. In order to receive a dividend, you should generally own the Hansoh Pharmaceutical Group Company stock before the ex-dividend date. The Dividend Calendar shows that the ex-day dates were last at June and September . Dividends from Hansoh Pharmaceutical Group Company are distributed via July and October.
Year | Dividend | Ex-day & Payday |
Frequency | |
---|---|---|---|---|
Fiscal Year | Dividend per Share | Ex-Day | Payday | Payment frequency |
2023 |
HKD0.201
HKD0.2
|
Sep 20 2024
Sep 20 2024
Oct 30 2024
Sep 20 24
Oct 30 24 |
Oct 30 2024 |
semi annual
semi-annual
|
2023 |
HKD0.1422
HKD0.14
|
Jun 19 2024
Jun 19 2024
Jul 17 2024
Jun 19 24
Jul 17 24 |
Jul 17 2024 |
semi annual
semi-annual
|
2022 |
HKD0.0707
HKD0.07
|
Sep 15 2023
Sep 15 2023
Sep 28 2023
Sep 15 23
Sep 28 23 |
Sep 28 2023 |
semi annual
semi-annual
|
2022 |
HKD0.05
HKD0.05
|
Jun 05 2023
Jun 05 2023
Jul 05 2023
Jun 05 23
Jul 05 23 |
Jul 05 2023 |
semi annual
semi-annual
|
2021 |
HKD0.05
HKD0.05
|
Sep 08 2022
Sep 08 2022
Sep 30 2022
Sep 08 22
Sep 30 22 |
Sep 30 2022 |
semi annual
semi-annual
|
2021 |
HKD0.09
HKD0.09
|
Jun 16 2022
Jun 16 2022
Jul 15 2022
Jun 16 22
Jul 15 22 |
Jul 15 2022 |
annual
yearly
|
2020 |
HKD0.0771
HKD0.08
|
Jun 07 2021
Jun 07 2021
Jul 05 2021
Jun 07 21
Jul 05 21 |
Jul 05 2021 |
annual
yearly
|
Hansoh Pharmaceutical Group Company most recently paid a dividend of HKD0.20. Hansoh Pharmaceutical Group Company paid a Dividend of HKD0.34 Per Share in the financial year 2023. With a stock price of HKD17.94 at Dec 20 2024, the current dividend yield is 1.91% (calculation: HKD0.34 / HKD17.94 = 1.91%). No special dividend was paid.
The average Hansoh Pharmaceutical Group Company dividend yield over the last 5 years is 0.60% and the average over the last 10 years is 0.30%.
The payout ratio of Hansoh Pharmaceutical Group Company in relation to the last financial year is 56.26%. The payout ratio smoothed over 3 years is 36.16%. The calculation is based on the sum of all dividend payments divided by the cumulative earnings per share(EPS).
Metric | Hansoh Pharmaceutical Group Company |
---|---|
Current dividend yield | 1.91% |
Dividend Yield 5Y | 0.60% |
Dividend Yield 10Y | 0.30% |
Payout 1Y | 56.26% |
Payout 3Y | 36.16% |
Hansoh Pharmaceutical Group Company has been paying a dividend for 4 years and has not reduced the dividend since 1 (dividend continuity). As a result, the dividend was recently increased 1-times.
The Dividend Growth in relation to the previous financial year amounts to 184.34%.
Metric | Hansoh Pharmaceutical Group Company |
---|---|
Increased | 1 Year |
Continuity | 1 Year |
Paid | 4 Years |
Growth 1Y | 184.34% |
Hansoh Pharmaceutical Group Company has been paying a dividend for 4 years and has not reduced the dividend since 1 (dividend continuity). As a result, the dividend was recently increased 1-times.
The Dividend Growth in relation to the previous financial year amounts to 184.34%.
On the stock exchange, the Hansoh Pharmaceutical Group Company stock (ISIN: KYG549581067) is not traded as a top scorer in December 2024 according to the dividend strategy.
The stock price of Hansoh Pharmaceutical Group Company 13.83% has risen since the beginning of the year 2024. However, the return generated in the past says nothing about the future return. You can find the Hansoh Pharmaceutical Group Company stock price in real time at the top of the page.
Hansoh Pharmaceutical Group Company (symbol: 3692) is valued at a Price / Earnings Ratio (P/E ratio) of 20.84 and a price/sales ratio (P/S ratio) of 8.13 valued. Based on analyst estimates, the Hansoh Pharmaceutical Group Company stock forecast 2024 of the current financial year corresponds to a valuation of 23.39 according to P/E ratio and 8.24 according to P/S.
Metric | Hansoh Pharmaceutical Group Company |
---|---|
Dividend Score | ??/15 |
Performance 2024 |
13.83%
|
P/E TTM | 20.84 |
P/S TTM | 8.13 |
P/E forward | 23.39 |
P/S forward | 8.24 |
Hansoh Pharmaceutical Group Company (symbol: 3692) is valued at a Price / Earnings Ratio (P/E ratio) of 20.84 and a price/sales ratio (P/S ratio) of 8.13 valued. Based on analyst estimates, the Hansoh Pharmaceutical Group Company stock forecast 2024 of the current financial year corresponds to a valuation of 23.39 according to P/E ratio and 8.24 according to P/S.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.